Brazil’s statement to the 64th World Health Assembly on the future of financing
64TH WORLD HEALTH ASSEMBLY
The future of financing for WHO A64/4
WHO REFORM AGENDA
Provisional agenda item 11STATEMENT BY THE BRAZILIAN DELEGATION
At the outset we would like to thank the report by the Director-General on WHO reform and its future financing for a healthy future. We acknowledge the efforts to reflect comments and suggestions presented by Member-States throughout the ongoing consultation process and believe the document is a good basis for our continued debate on this important issue.
USPTO statement at WIPO side event on Medicines Patent Pool
This is the statement that was delivered by Karin L. Ferriter (from USPTO and USTR), at a UNITAID side event on the Medicines Patent Pool, during a break of the WIPO Standing Committee on the Law of Patents.
Statement on Medicines Patent Pool Side EventWIPO SCP16: Joint proposal of the African Group and the Development Agenda Group on a work program on Patents and Health
Update: The proposal has now been formally published on the WIPO web site as SCP/16/7.NGO Statement on WHO governance and the Management of Conflicts of Interest and the Future of Financing for WHO
NGO Statement on WHO governance and the Management of Conflicts of Interest and the Future of Financing for WHO.
May 18, 2011
We write to express our concerns about governance of the World Health Organization (WHO) and other public health bodies, as regards the management of conflicts of interest.
SCP16: Slide presentations of Professor Carlos Correa, Judit Rius Sanjuan and James Love at KEI briefing on Patents and Health
On 17 May 2011, Knowledge Ecology International (KEI) organized a Briefing on Patents and Health at WIPO’s 16h session of the Standing Committee on Patents (SCP). Continue Reading
KEI comments to the WIPO patent committee discussion of patent quality
During today’s discussion at the WIPO Standing Committee on the Law of Patents (SCP) on patent quality KEI make four points in its intervention.
1. WIPO should consider gathering information on the costs of litigation to challenge the validity of patents.
2. WIPO should consider creating a database to share information on the cases where litigation has resulted findings that patent claims as invalid.
WIPO patent committee discusses Exception and Limitations to Patent Rights
The World Intellectual Property Organization (WIPO) has convened the 16th session of the WIPO Standing Committee on the Law of Patents (SCP). The SCP elected Albert Tramposch, Administrator for Policy and External Affairs, USPTO as Chair.
Save the Date-17 May 2011-KEI @ WIPO Standing Committee on the Law of Patents: Patents and Health
Knowledge Ecology International: Patents and HealthDATE: Tuesday, 17 May 2011
TIME: 13:30-15h00
VENUE: Room B at the WIPO Main Building
Dramatic increase in waiting lists for AIDS Drug Assistance Programs, January 2010 to May 2011
AIDS Drug Assistance Programs (ADAP) are state run programs that provide medicines to low-income HIV-positive patients who either have limited or no insurance coverage. ADAPs are essential in providing life-saving medicines to low-income patients, but these programs are threatened by the high costs of treatment.
Dr. Balasubramaniam
On April 19, 2011, Dr Kumariah Balasubramaniam died at his home in Sri Lanka. Dr. Balasubramaniam, known to many as Dr. Bala, was described by Professor Colvin Gooneratne as “one of the most knowledgeable, resolute, articulate, versatile, resilient and in many other ways exceptionally brilliant health activists [the world] has produced.” My tribute to Dr. Bala is in the Huffington Post. Prof. Continue Reading